Kalaris Therapeutics, Inc. · NASDAQ:KLRS
Kalaris Therapeutics, Inc. insider trades
Kalaris Therapeutics, Inc.'s insiders made 1 buy and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.
| Date | Insider | Trade | Shares | Price | Filing |
|---|---|---|---|---|---|
| May 20, 2026 | Srinivas Akkaraju | Buy | 244,300 | US$5 | Form 4 |